• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝吖啶在体外与染色质中DNA的结合。

In vitro binding of nitracrine to DNA in chromatin.

作者信息

Wilmańska D, Szmigiero L, Gniazdowski M

机构信息

Department of General Chemistry, Institute of Physiology and Biochemistry, School of Medicine, Lódź, Poland.

出版信息

Z Naturforsch C J Biosci. 1989 Mar-Apr;44(3-4):307-11. doi: 10.1515/znc-1989-3-420.

DOI:10.1515/znc-1989-3-420
PMID:2742691
Abstract

In the presence of sulfhydryl compounds nitracrine, an anticancer drug, binds covalently to DNA. The accessibility of DNA in chromatin both to nitracrine and to 8-methoxypsoralen, which was used as a reference compound in this study, when assayed in NaCl concentrations from 0 to 2 M show similar characteristics. The initial decrease reaches a minimum at 0.15 M NaCl above which dissociation of non-histone proteins and histones at higher ionic strengths is demonstrated by an increase in accessible sites. The relative accessibility of DNA in chromatin to nitracrine is, however, lower than that found for 8-methoxypsoralen. Partial dissociation of chromatin with 0.7 M NaCl increases the accessibility of DNA in chromatin when assayed in the absence of NaCl but has no apparent influence when estimated at ionic strength close to physiological conditions.

摘要

在巯基化合物存在的情况下,抗癌药物硝吖啶会与DNA共价结合。当在0至2M的NaCl浓度下进行测定时,染色质中DNA对硝吖啶和8-甲氧基补骨脂素(本研究中用作参考化合物)的可及性表现出相似的特征。最初的下降在0.15M NaCl时达到最小值,高于此浓度时,较高离子强度下非组蛋白和组蛋白的解离通过可及位点的增加得以证明。然而,染色质中DNA对硝吖啶的相对可及性低于8-甲氧基补骨脂素。用0.7M NaCl对染色质进行部分解离,在无NaCl条件下测定时会增加染色质中DNA的可及性,但在接近生理条件的离子强度下估算时则没有明显影响。

相似文献

1
In vitro binding of nitracrine to DNA in chromatin.硝吖啶在体外与染色质中DNA的结合。
Z Naturforsch C J Biosci. 1989 Mar-Apr;44(3-4):307-11. doi: 10.1515/znc-1989-3-420.
2
Effect of intercalating and groove-binding ligands on formation of covalent complexes between nitracrine (Ledakrin, C-283) or 8-methoxypsoralen and DNA.嵌入和沟槽结合配体对硝吖啶(雷达克林,C - 283)或8 - 甲氧基补骨脂素与DNA之间共价复合物形成的影响。
Biochim Biophys Acta. 1984 Jul 18;782(3):285-94. doi: 10.1016/0167-4781(84)90064-2.
3
Some properties of the irreversible complexes of nitracrine (ledakrin, C-283) with polynucleotides.硝吖啶(雷达克林,C - 283)与多核苷酸的不可逆复合物的某些性质。
Chem Biol Interact. 1981 Mar 15;34(3):355-66. doi: 10.1016/0009-2797(81)90107-1.
4
32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.用32P后标记分析法研究抗肿瘤药物硝吖啶(雷得菌素)及其他硝基吖啶在不同生物系统中形成DNA加合物的情况。
Biochem Pharmacol. 1989 Apr 15;38(8):1301-12. doi: 10.1016/0006-2952(89)90337-7.
5
Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.缺氧选择性抗肿瘤剂。2. 4-取代基对尼曲吖啶衍生物细胞毒性机制和代谢稳定性的电子效应。
J Med Chem. 1989 Jan;32(1):31-8. doi: 10.1021/jm00121a007.
6
Modification of histone binding in calf thymus chromatin by protamine.鱼精蛋白对小牛胸腺染色质中组蛋白结合的修饰作用。
Biochemistry. 1975 Jan 14;14(1):122-7. doi: 10.1021/bi00672a021.
7
[Is the binding strength of histone fractions with DNA different?].[组蛋白组分与DNA的结合强度是否不同?]
Biull Eksp Biol Med. 1980 Aug;90(8):163-5.
8
32P-post-labelling analysis of nucleobases involved in the formation of DNA adducts by antitumor 1-nitroacridines.通过抗肿瘤1-硝基吖啶形成DNA加合物所涉及的核碱基的32P后标记分析
Chem Biol Interact. 1997 Feb 28;103(2):131-9. doi: 10.1016/s0009-2797(96)03753-2.
9
Transcriptional template activity of covalently modified DNA.共价修饰DNA的转录模板活性。
Mutat Res. 1997 Mar 4;374(1):139-43. doi: 10.1016/s0027-5107(96)00186-8.
10
The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.细胞毒性和抗肿瘤1-硝基吖啶的作用模式。II. 1-硝基吖啶衍生物(雷达克林或硝吖啶)在体内通过酶介导与哺乳动物或细菌细胞的DNA及其他大分子的共价结合
Chem Biol Interact. 1983 Feb;43(2):151-73. doi: 10.1016/0009-2797(83)90093-5.

引用本文的文献

1
Absorption and luminescence spectroscopic analysis of tautomeric forms of protonatedN,N-dimethyl-N'-(1-nitro-9-acridinyl)-1,3-propanediamine (nitracrine) and its nitro isomers in poly(vinyl alcohol) films.质子化 N,N-二甲基-N'-(1-硝基-9-吖啶基)-1,3-丙二胺(硝卡嗪)及其硝基异构体在聚乙烯醇薄膜中的互变异构形式的吸收和荧光光谱分析。
J Fluoresc. 1991 Mar;1(1):57-68. doi: 10.1007/BF00865259.